GLPG1205: Clinical Trials

2 trials of GLPG1205, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow GLPG1205: new trials by email Literature Review of GLPG1205 trials Research Report on GLPG1205

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)
GLPG1205, Placebo - Idiopathic Pulmonary Fibrosis
Phase 2CompletedLakefront Biotherapeutics NV682018-09-272021-09-14
Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis
GLPG1205, Placebo - Ulcerative Colitis
Phase 2CompletedLakefront Biotherapeutics NV642014-12-012015-11-20

Conditions studied

Colitis, Ulcerative (1)  ·  Idiopathic Pulmonary Fibrosis (1)

Sponsors

Lakefront Biotherapeutics NV (2)

Countries

Belgium (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Oman (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Slovakia (1)  ·  Sweden (1)  ·  Ukraine (1)

Top investigators

Christian Seemayer, MD (1)

Results publications

PMID 36328358

NIH funding

2014 (1), 2017 (1)